Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

NCT06750185 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

BIOLOGICAL: BNT317 DL1
BIOLOGICAL: BNT317 DL2
BIOLOGICAL: BNT317 DL3
BIOLOGICAL: BNT317 DL4
BIOLOGICAL: BNT317 DL5 (intermediate)
BIOLOGICAL: BNT317 DL6 (intermediate)
BIOLOGICAL: BNT317 DL7 (additional)

Sponsor

BioNTech SE